3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Neoplasms
1
Motor Activity
1
Inflammatory Bowel Diseases
1
Diabetes Mellitus
1
Cachexia
1
Arthritis, Juvenile
1
Anorexia Nervosa
1
Interventions
Megestrol Acetate
9
Exercise
6
Standard of Care
4
Olanzapine
3
Ibuprofen
3
Blood Specimen Collection
3
anamorelin
2
Resistance Training
2
Physical Therapy Modalities
2
Nutrition Assessment
2
Mirtazapine
2
Melatonin
2
Infliximab
2
Dietary Supplements
2
Diet Therapy
2
Cyproheptadine
2
testosterone enanthate
1
remune
1
ostarine
1
olanzapine-fluoxetine combination
1
nabiximols
1
nabilone
1
irinotecan sucrosofate
1
fucoidan
1
dermcidin
1
clazakizumab
1
bermekimab
1
alkaloid GB18
1
Vitamin D
1
Sodium Chloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cachexia
×
Calorimetry, Indirect
×
Clear all
NCT02500004
2018-08-03
BAT-Cachexia
Maastricht University Medical Center
Phase NA
Completed
16 enrolled